The World's Greatest Investing Community
Results 1 - 10 of 144 : 1 2 3 4 5 6 7 8 9 Next
Greece Steals the Dow's Lunch Money
Greece worries the Dow.
What These Winning Investments Can Teach You
Top performers in the ETF world have lessons for those who listen.
Hostile Takeover? More Like Nice Guy Showdown.
Glaxo takes off the gloves and puts on oven mitts in bid to get Human Genome Sciences.
Glaxo Goes Hostile With $2.6 Billion Bid
GlaxoSmithKline takes its $13-a-share offer directly to Human Genome Sciences' owners.
Dow Poised for Further Losses?
European concerns continue to dominate the news and are likely to push the Dow lower.
Is Human Genome Sciences the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Stocks Shaking the Investment World
These stocks caused the markets to tremble this past month.
Human Genome Lays Out Its Valuation Case
First-quarter earnings? What's that?
These companies made big headlines -- what does it mean for you?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK